Bioavailability and activity of topical corticosteroids from a novel drug delivery system, the aerosol quick-break foam.
Experiments were conducted to: (a) compare the bioavailability of betamethasone benzoate in a quick-break aerosol foam and semisolid dosage forms, (b) compare the activity of betamethasone benzoate, betamethasone valerate, clobetasol propionate, triamcinolone acetonide, desonide, flumethasoid reservoir formation in skin, and (d) assess the effect of a natural moisturizer. Efficacy was determined by a graded response 6-hr occluded vasoconstriction test with subsequent reocclusion for reservoir demonstration. Moisturizer effect was assessed by a nonoccluded vasoconstriction test using "plain" and sodium 2-pyrrolidone-5-carboxylate-containing concentrates on arms pretreated with water or moisturizer. The activities of betamethasone benzoate concentrate, collapsed foam, ointment, and gel were similar and significantly better than the activity of the cream. Clobetasol propionate was significantly better than the other medicated concentrates, which were equivalent. Steroid-induced blanching decreased in the presence of a moisturizer.
D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000378:metabolism / Q000494:pharmacology; D000336:Aerosols; D001623:Betamethasone / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology; D001682:Biological Availability; D002626:Chemistry, Pharmaceutical; D002986:Clinical Trials as Topic; D004347:Drug Interactions; D005260:Female; D005782:Gels; D006801:Humans; D008297:Male; D009824:Ointments; D010167:Pallor / Q000139:chemically induced; D011761:Pyrrolidonecarboxylic Acid / Q000494:pharmacology
D000305:Adrenal Cortex Hormones; D000336:Aerosols; D005782:Gels; D009824:Ointments; D001623:Betamethasone; D011761:Pyrrolidonecarboxylic Acid